相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LncRNAs and the Angiogenic Switch in Cancer: Clinical Significance and Therapeutic Opportunities
Peace Mabeta et al.
GENES (2022)
Tumors resurrect an embryonic vascular program to escape immunity
Elisabeth J. M. Huijbers et al.
SCIENCE IMMUNOLOGY (2022)
How VEGF-A and its splice variants affect breast cancer development - clinical implications
Hivin Al Kawas et al.
CELLULAR ONCOLOGY (2022)
Relationship between VEGF Family Members, Their Receptors and Cell Death in the Neoplastic Transformation of Colorectal Cancer
Dominika Dakowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Targeting the spliceosome machinery: A new therapeutic axis in cancer?
Beatrice Eymin
BIOCHEMICAL PHARMACOLOGY (2021)
Hypoxia-induced alternative splicing in human diseases: the pledge, the turn, and the prestige
Subhashis Natua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Splicing factors: Insights into their regulatory network in alternative splicing in cancer
Jun-Xian Du et al.
CANCER LETTERS (2021)
Alternative splicing: An important regulatory mechanism in colorectal carcinoma
Jianyi Wang et al.
MOLECULAR CARCINOGENESIS (2021)
eNOS and VEGF Variants Might Increase the Risk of Pancreatic Cancer
Hasan Dagmura et al.
CYTOLOGY AND GENETICS (2021)
A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties
Eleanor Star et al.
ONCOGENESIS (2021)
USP39 promotes malignant proliferation and angiogenesis of renal cell carcinoma by inhibiting VEGF-A165b alternative splicing via regulating SRSF1 and SRPK1
Xiu-wu Pan et al.
CANCER CELL INTERNATIONAL (2021)
Alternative RNA Splicing-The Trojan Horse of Cancer Cells in Chemotherapy
Nikolay Mehterov et al.
GENES (2021)
Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models
Claudia Ceci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
VEGF-A165b levels are reduced in breast cancer patients at primary diagnosis but increase after completion of cancer treatment
Maria Margarete Karsten et al.
SCIENTIFIC REPORTS (2020)
Intussusceptive angiogenesis as a key therapeutic target for cancer therapy
Sekaran Saravanan et al.
LIFE SCIENCES (2020)
Overexpression ofVEGF165is associated with poor prognosis of cervical cancer
Kinjal A. Patel et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
VEGF-A splice variants bind VEGFRs with differential affinities
Spencer B. Mamer et al.
SCIENTIFIC REPORTS (2020)
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
Asma Boudria et al.
ONCOGENE (2019)
VEGF in Signaling and Disease: Beyond Discovery and Development
Rajendra S. Apte et al.
CELL (2019)
Alternative Splicing in Angiogenesis
Elizabeth Bowler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
P-039Vascular endothelial growth factor (VEGF) splice isoforms may hold the key to targeting tumour angiogenesis in oesophageal cancer
F Mehedi
ANNALS OF ONCOLOGY (2018)
Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1
Cristina M. Failla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
New Insights in Anti-Angiogenesis in Multiple Myeloma
Domenico Ribatti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer
Miriam Canavese et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
VEGFR1 promotes cell migration and proliferation through PLC gamma and PI3K pathways
Jared C. Weddell et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2017)
A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
Andrew M. Evens et al.
CLINICAL CANCER RESEARCH (2016)
Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma
Sarit E. Assouline et al.
BLOOD (2016)
VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans
M. Kazemi et al.
CANCER GENE THERAPY (2016)
Effects of receptor tyrosine kinase inhibitors on VEGF165a- and VEGF165b-stimulated gene transcription in HEK-293 cells expressing human VEGFR2
Joanne J. Carter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Vascular endothelial growth factor: Therapeutic possibilities and challenges for the treatment of ischemia
Trevor D. Crafts et al.
CYTOKINE (2015)
Inhibition of phosphoinositide 3-kinase is associated with reduced angiogenesis and an altered expression of angiogenic markers in endothelioma cells
P. Mabeta
BIOMEDICINE & PHARMACOTHERAPY (2014)
An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease
Ryosuke Kikuchi et al.
NATURE MEDICINE (2014)
Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia
R. P. Hulse et al.
NEUROBIOLOGY OF DISEASE (2014)
The VEGF pathway in lung cancer
Michalis Alevizakos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Regulation of angiogenesis by PI3K signaling networks
Mariona Graupera et al.
EXPERIMENTAL CELL RESEARCH (2013)
Antiangiogenic VEGF Isoform in Inflammatory Myopathies
Nila Volpi et al.
MEDIATORS OF INFLAMMATION (2013)
Inhibition of hemangioma development in a syngeneic mouse model correlates with bcl-2 suppression and the inhibition of Akt kinase activity
Peace Mabeta et al.
ANGIOGENESIS (2012)
The role of VEGF165b in pathophysiology
Maria Peiris-Pages
CELL ADHESION & MIGRATION (2012)
VEGF Spliced Variants: Possible Role of Anti-Angiogenesis Therapy
Caroline Hilmi et al.
JOURNAL OF NUCLEIC ACIDS (2012)
Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis
Mirko Manetti et al.
CIRCULATION RESEARCH (2011)
VEGF as a Biomarker for Metastatic Uveal Melanoma in Humans
Vivian Barak et al.
CURRENT EYE RESEARCH (2011)
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors
Helena Pavlakovic et al.
LYMPHATICS IN THE DIGESTIVE SYSTEM: PHYSIOLOGY, HEALTH, AND DISEASE (2010)
Pathways mediating VEGF-independent tumor angiogenesis
Napoleone Ferrara
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A
Raul Catena et al.
MOLECULAR CANCER (2010)
A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents
Peace Mabeta et al.
ANGIOGENESIS (2009)
Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling
Andrew N. Makanya et al.
ANGIOGENESIS (2009)
Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
Jeanette Woolard et al.
MICROCIRCULATION (2009)
VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma:: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
A. H. R. Varey et al.
BRITISH JOURNAL OF CANCER (2008)
The endogenous anti-angiogenic VEGF isoform, VEGF(165)b inhibits human tumour growth in mice
E. S. Rennel et al.
BRITISH JOURNAL OF CANCER (2008)
Vascular endothelial growth factor (VEGF)-A165b is a weak in vitro agonist for VEGF receptor-2 due to lack of coreceptor binding and deficient regulation of kinase activity
Harukiyo Kawamura et al.
CANCER RESEARCH (2008)
Distinct signaling pathways confer different vascular responses to VEGF 121 and VEGF 165
Yan Zhang et al.
GROWTH FACTORS (2008)
VEGF 121 promotes lymphangiogenesis in the sentinel lymph nodes of non-small cell lung carcinoma patients
Hideki Kawai et al.
LUNG CANCER (2008)
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
Masatoshi Jinnin et al.
NATURE MEDICINE (2008)
Microenvironment Changes (in pH) Affect VEGF Alternative Splicing
Ana Paula Elias et al.
CANCER MICROENVIRONMENT (2008)
VEGF-A splicing: the key to anti-angiogenic therapeutics?
Steven J. Harper et al.
NATURE REVIEWS CANCER (2008)
Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents
Pierre Mineur et al.
JOURNAL OF CELL BIOLOGY (2007)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
R. O. Pritchard-Jones et al.
BRITISH JOURNAL OF CANCER (2007)
Increased expression of VEGF121/VEGF165-189 ratio results in a significant enhancement of human prostate tumor angiogenesis
Raul Catena et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA
MA Hervé et al.
EXPERIMENTAL CELL RESEARCH (2005)
Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer
H Bando et al.
BRITISH JOURNAL OF CANCER (2005)
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
A Luttun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
VEGF165b, an inhibitory vascular endothelial growth factor splice variant:: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression
J Woolard et al.
CANCER RESEARCH (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth fact or receptor 2 in an in vitro angiogenesis model
MN Nakatsu et al.
LABORATORY INVESTIGATION (2003)
Mechanisms of normal and tumor-derived angiogenesis
M Papetti et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding
S Soker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways
BK Lal et al.
MICROVASCULAR RESEARCH (2001)
VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase
JH Qi et al.
EXPERIMENTAL CELL RESEARCH (2001)
Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival
S Ugurel et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer
A Yuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
